Topical Corticosteroid Switches Must Overcome Side Effect Concerns – Panel

Topical corticosteroid manufacturers will have to overcome a high burden of proof to convince FDA that side effects related to cortisol suppression from using the drugs are outweighed by their benefits when seeking an Rx-to-OTC switch